Vaccine priming of rare HIV broadly neutralizing antibody precursors in nonhuman primates

非人灵长类动物中罕见HIV广谱中和抗体前体的疫苗启动

阅读:3
作者:Jon M Steichen # ,Ivy Phung # ,Eugenia Salcedo # ,Gabriel Ozorowski # ,Jordan R Willis ,Sabyasachi Baboo,Alessia Liguori ,Christopher A Cottrell ,Jonathan L Torres ,Patrick J Madden,Krystal M Ma ,Henry J Sutton,Jeong Hyun Lee ,Oleksandr Kalyuzhniy ,Joel D Allen,Oscar L Rodriguez,Yumiko Adachi ,Tina-Marie Mullen ,Erik Georgeson ,Michael Kubitz ,Alison Burns ,Shawn Barman ,Rohini Mopuri,Amanda Metz,Tasha K Altheide,Jolene K Diedrich,Swati Saha,Kaitlyn Shields,Steven E Schultze,Melissa L Smith,Torben Schiffner ,Dennis R Burton ,Corey T Watson,Steven E Bosinger,Max Crispin,John R Yates rd,James C Paulson ,Andrew B Ward ,Devin Sok ,Shane Crotty ,William R Schief

Abstract

Germline-targeting immunogens hold promise for initiating the induction of broadly neutralizing antibodies (bnAbs) to HIV and other pathogens. However, antibody-antigen recognition is typically dominated by heavy chain complementarity determining region 3 (HCDR3) interactions, and vaccine priming of HCDR3-dominant bnAbs by germline-targeting immunogens has not been demonstrated in humans or outbred animals. In this work, immunization with N332-GT5, an HIV envelope trimer designed to target precursors of the HCDR3-dominant bnAb BG18, primed bnAb-precursor B cells in eight of eight rhesus macaques to substantial frequencies and with diverse lineages in germinal center and memory B cells. We confirmed bnAb-mimicking, HCDR3-dominant, trimer-binding interactions with cryo-electron microscopy. Our results demonstrate proof of principle for HCDR3-dominant bnAb-precursor priming in outbred animals and suggest that N332-GT5 holds promise for the induction of similar responses in humans.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。